Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients with Nonmetastatic Ewing Sarcoma: A Children’s Oncology Group Report

Patrick J. Leavey, Nadia N. Laack, Mark D. Krailo, Allen Buxton, R. Lor Randall, Steven G. DuBois, Damon R. Reed, Holcombe E. Grier, Douglas S. Hawkins, Bruce Pawel, Helen Nadel, Richard B. Womer, G. Douglas Letson, Mark Bernstein, Kenneth Brown, Alexis Maciej, Paul Chuba, Atif A. Ahmed, Daniel J. Indelicato, Dian WangNeyssa Marina, Richard Gorlick, Katherine A. Janeway, Leo Mascarenhas

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients with Nonmetastatic Ewing Sarcoma: A Children’s Oncology Group Report'. Together they form a unique fingerprint.

Medicine & Life Sciences